Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma faces $2 billion cut in drugs bill as Greece debt crisis deepens

This article was originally published in Scrip

Executive Summary

Pharmaceutical companies are likely to be reeling today with the announcement that €2.1 billion ($2.8 billion) of healthcare spending cuts will take place during 2011–15 in Greece. These cuts will be implemented through widening the use of electronic prescribing, and drug price cuts. This will not only negatively impact pharmaceutical company sales in Greece, but also sales in other countries which reference Greek drug prices.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC013516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel